Accès ouvert

Review of: "Outcomes of Rezum Water Vapor Therapy for Benign Prostate Obstruction with One-Year Follow-Up: Largest Real-World Data from Türkiye"

Article scientifique 2024 Anglais

Résumé

Potential competing interests: No potential competing interests to declare.1-Authors neglect references related to methods of determination of PVR ( Rubilotta et al. 2021), IPSS, Qol, Qmax, etc… 2-The sample size in this study is small to build a conclusion about the benefits of Rezum water vapor.3-The study lacks a normal group of volunteers.4-Total PSA is not an accurate marker to exclude the presence of prostate cancer.It is known that prostate cancer risk lies between 4-10 ng/ml, but there are many cases that have no cancer in this range, and oppositely, there are many cancer cases that occur for patients who have a total PSA less than 4.5-Free PSA: total PSA is more accurate.A ratio less than 25% is diagnostic for prostate cancer.Why did the authors not determine the ratio to be sure about the exclusion criteria?

Citer ce document

Elrehany, M. (2024). Review of: "Outcomes of Rezum Water Vapor Therapy for Benign Prostate Obstruction with One-Year Follow-Up: Largest Real-World Data from Türkiye". https://doi.org/10.32388/pcpywl

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Auteur(s)

Mahmoud A. Elrehany

Statistiques

Consultations : 1

Téléchargements : 0